Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.
Gibiansky E, Petry C, Mercier F, Günther A, Herman A, Kappos L, Hauser S, Yamamoto Y, Wang Q, Model F, Kletzl H. Gibiansky E, et al. Among authors: mercier f. Br J Clin Pharmacol. 2021 Jun;87(6):2511-2520. doi: 10.1111/bcp.14658. Epub 2020 Dec 7. Br J Clin Pharmacol. 2021. PMID: 33202059 Free PMC article. Clinical Trial.
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.
Selmaj K, Li DK, Hartung HP, Hemmer B, Kappos L, Freedman MS, Stüve O, Rieckmann P, Montalban X, Ziemssen T, Auberson LZ, Pohlmann H, Mercier F, Dahlke F, Wallström E. Selmaj K, et al. Among authors: mercier f. Lancet Neurol. 2013 Aug;12(8):756-67. doi: 10.1016/S1474-4422(13)70102-9. Epub 2013 Jun 11. Lancet Neurol. 2013. PMID: 23764350 Clinical Trial.
A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxel.
Xu C, Ravva P, Dang JS, Laurent J, Adessi C, McIntyre C, Meneses-Lorente G, Mercier F. Xu C, et al. Among authors: mercier f. Cancer Chemother Pharmacol. 2018 Sep;82(3):395-406. doi: 10.1007/s00280-018-3621-9. Epub 2018 Jun 18. Cancer Chemother Pharmacol. 2018. PMID: 29915982
Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission.
González-Sales M, Djebli N, Meneses-Lorente G, Buchheit V, Bonnefois G, Tremblay PO, Frey N, Mercier F. González-Sales M, et al. Among authors: mercier f. Cancer Chemother Pharmacol. 2021 Dec;88(6):997-1007. doi: 10.1007/s00280-021-04353-8. Epub 2021 Sep 18. Cancer Chemother Pharmacol. 2021. PMID: 34536094 Clinical Trial.
524 results